| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Camp4 Therapeutics Corp | 10%+ Owner | Common Stock | 197,661 | $302,421 | $1.53 | 11 Sep 2025 | Indirect |
| Camp4 Therapeutics Corp | 10%+ Owner | Series A Prime Preferred Stock | 0 | 15 Oct 2024 | Indirect | ||
| Camp4 Therapeutics Corp | 10%+ Owner | Series B Preferred Stock | 0 | 15 Oct 2024 | Indirect |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CAMP | Camp4 Therapeutics Corp | 11 Sep 2025 | 2 | +$1,999,999 | 4 | 10%+ Owner | 11 Sep 2025, 16:59 |
| CAMP | Camp4 Therapeutics Corp | 15 Oct 2024 | 9 | +$9,999,990 | 4/A | 10%+ Owner | 22 Oct 2024, 17:31 |
| CAMP | Camp4 Therapeutics Corp | 10 Oct 2024 | 0 | $0 | 3 | 10%+ Owner | 10 Oct 2024, 21:34 |